|
|
||||||||
Double-Mutant Mice Resist Septic Arthritis but Display Increased Mortality in Response to Staphylococcus aureus1


*
Department of Rheumatology, University of Göteborg, Göteborg, Sweden;
Section of Clinical Immunology, University Hospital Zurich, Switzerland;
Centenary Institute of Cancer Medicine and Cell Biology, Sydney, Australia; and
§
Institute for Neurobiology, Hygiene and Immunology, Erlangen, Germany
To evaluate the importance of the proinflammatory cytokines TNF and
lymphotoxin-
(LT
) in an experimental model of
Staphylococcus aureus sepsis and arthritis, we used
TNF/LT
-double-deficient mice raised on the C57BL/6 background. Mice
were i.v. inoculated with a toxic shock syndrome toxin-1
(TSST-1)-producing S. aureus strain, LS-1. Intravenous
inoculation of a high dose of bacteria (1 x
107/mouse) resulted in 67% mortality in
TNF/LT
-deficient mice, whereas none of the controls died
(p = 0.009). Those results correlated to a
significantly decreased phagocytosis in vitro and inefficient bacterial
clearance in vivo in mice lacking capacity to produce TNF/LT
. Thus,
at day 6 after inoculation, S. aureus could not be found
in the bloodstream of controls, but bacteremia developed in all
TNF/LT
-deficient mice examined (p = 0.02).
Interestingly, upon infection with a lower dose of staphylococci
(3 x 106/mouse) the mortality was overall low, but
the frequency of arthritis was clearly higher in the wild-type group as
compared with the TNF/LT
-deficient mice (40% vs 13%).
Histopathologic examination revealed a lower frequency of synovitis
(38% vs 90%, p < 0.05) and erosivity (25% vs
60%, NS) in TNF/LT
-deficient mice as compared with wild-type
counterparts. Our results show the importance of TNF/LT
in defense
against systemic S. aureus infections and point out the
detrimental role of these cytokines as mediators of inflammatory
response in S. aureus arthritis.
This article has been cited by other articles:
![]() |
P. B. Mann, K. D. Elder, M. J. Kennett, and E. T. Harvill Toll-Like Receptor 4-Dependent Early Elicited Tumor Necrosis Factor Alpha Expression Is Critical for Innate Host Defense against Bordetella bronchiseptica Infect. Immun., November 1, 2004; 72(11): 6650 - 6658. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zare, M. Bokarewa, N. Nenonen, T. Bergstrom, L. Alexopoulou, R. A. Flavell, and A. Tarkowski Arthritogenic Properties of Double-Stranded (Viral) RNA J. Immunol., May 1, 2004; 172(9): 5656 - 5663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakurai, N. Okahashi, I. Nakagawa, S. Kawabata, A. Amano, T. Ooshima, and S. Hamada Streptococcus pyogenes Infection Induces Septic Arthritis with Increased Production of the Receptor Activator of the NF-{kappa}B Ligand Infect. Immun., October 1, 2003; 71(10): 6019 - 6026. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Hultgren, L. Svensson, and A. Tarkowski Critical Role of Signaling Through IL-1 Receptor for Development of Arthritis and Sepsis During Staphylococcus aureus Infection J. Immunol., May 15, 2002; 168(10): 5207 - 5212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Ferraccioli, F Mecchia, E Di Poi, and M Fabris Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections Ann Rheum Dis, April 1, 2002; 61(4): 358 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schumann, D. Wolf, A. Pahl, K. Brune, T. Papadopoulos, N. van Rooijen, and G. Tiegs Importance of Kupffer Cells for T-Cell-Dependent Liver Injury in Mice Am. J. Pathol., November 1, 2000; 157(5): 1671 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Nair, R. J. Williams, and B. Henderson Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection Rheumatology, August 1, 2000; 39(8): 821 - 834. [Full Text] [PDF] |
||||
![]() |
D. Ito, T. C. Back, A. N. Shakhov, R. H. Wiltrout, and S. A. Nedospasov Mice with a Targeted Mutation in Lymphotoxin-{alpha} Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment J. Immunol., September 1, 1999; 163(5): 2809 - 2815. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |